Should I buy or sell Cryoport stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last twelve months. There are currently 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CYRX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CYRX, but not buy additional shares or sell existing shares. View CYRX analyst ratings or view top-rated stocks .

What is Cryoport's stock price target for 2024?

7 brokerages have issued 12-month price targets for Cryoport's shares. Their CYRX share price targets range from $10.00 to $28.00. On average, they predict the company's stock price to reach $18.63 in the next twelve months. This suggests a possible upside of 15.5% from the stock's current price. View analysts price targets for CYRX or view top-rated stocks among Wall Street analysts .

How have CYRX shares performed in 2024?

Cryoport's stock was trading at $15.49 at the start of the year. Since then, CYRX shares have increased by 4.1% and is now trading at $16.13. View the best growth stocks for 2024 here .

When is Cryoport's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our CYRX earnings forecast .

How were Cryoport's earnings last quarter?

Cryoport, Inc. (NASDAQ:CYRX) announced its earnings results on Tuesday, March, 12th. The company reported ($0.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.32) by $0.19. The business earned $57.26 million during the quarter, compared to the consensus estimate of $58.27 million. Cryoport had a negative trailing twelve-month return on equity of 11.86% and a negative net margin of 42.69%.

What ETF holds Cryoport's stock?

Inspire Small/Mid Cap ETF holds 20,223 shares of CYRX stock, representing 0.21% of its portfolio.

What guidance has Cryoport issued on next quarter's earnings?

Cryoport updated its FY 2024 earnings guidance on Tuesday, March, 12th. The company provided EPS guidance of for the period. The company issued revenue guidance of $242.0 million-$252.0 million, compared to the consensus revenue estimate of $253.2 million.

What other stocks do shareholders of Cryoport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD) , Advanced Micro Devices (AMD) , Micron Technology (MU) , NVIDIA (NVDA) , Taiwan Semiconductor Manufacturing (TSM) , Amarin (AMRN) , QUALCOMM (QCOM) , Enterprise Products Partners (EPD) , Pfizer (PFE) and Block (SQ) .

Who are Cryoport's major shareholders?

Cryoport's stock is owned by a number of institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (0.33%). Insiders that own company stock include Daniel M Hancock, Daniel M Hancock , Edward J Zecchini , Freeze Parent LP Blackstone, Jerrell Shelton , Mark W Sawicki , Michael R Egeck, Ramkumar Mandalam, Richard J Berman , Robert J Hariri and Robert Stefanovich . View institutional ownership trends .

How do I buy shares of Cryoport?

Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CYRX

Cryoport (CYRX) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free CYRX Stock Alerts

$16.13

-0.34 (-2.06%)

(As of 04/19/2024 ET)

Compare

Today's Range: $15.59
▼
$16.73
50-Day Range: $14.36
▼
$18.83
52-Week Range: $9.00
▼
$24.17

Volume: 514,632 shs
Average Volume: 422,799 shs
Market Capitalization: $792.95 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $18.63

Get Cryoport alerts:

Cryoport MarketRank™ Stock Analysis

Analyst Rating: Hold
2.29 Rating Score
Upside/Downside: 15.5% Upside
$18.63 Price Target
Short Interest: Bearish
8.57% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Selling Shares
$1.15 M Sold Last Quarter
Proj. Earnings Growth: Growing
From ($1.31) to ($1.13) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.73 out of 5 stars

Transportation Sector

102nd out of 110 stocks

Pharmaceutical Preparations Industry

381st out of 411 stocks

2.1

Analyst's Opinion

Consensus Rating
Cryoport has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on 2 buy ratings, 5 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Cryoport has only been the subject of 4 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
8.57% of the float of Cryoport has been sold short.
Short Interest Ratio / Days to Cover
Cryoport has a short interest ratio ("days to cover") of 8.9.
Change versus previous month
Short interest in Cryoport has recently decreased by 2.64%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Cryoport does not currently pay a dividend.
Dividend Growth
Cryoport does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CYRX.

0.6

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for Cryoport this week, compared to 3 articles on an average week.
Search Interest
Only 1 people have searched for CYRX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
MarketBeat Follows
2 people have added Cryoport to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cryoport insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,147,538.00 in company stock.
Percentage Held by Insiders
10.10% of the stock of Cryoport is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
92.90% of the stock of Cryoport is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Cryoport are expected to grow in the coming year, from ($1.31) to ($1.13) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cryoport is -7.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cryoport is -7.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cryoport has a P/B Ratio of 1.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Cryoport Stock (NASDAQ:CYRX)

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

CYRX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CYRX Stock News Headlines

March 27, 2024 | insidertrades.com

Robert Stefanovich Sells 1,079 Shares of Cryoport, Inc. (NASDAQ:CYRX) Stock

March 20, 2024 | insidertrades.com

Robert Stefanovich Sells 1,035 Shares of Cryoport, Inc. (NASDAQ:CYRX) Stock

April 20, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

March 20, 2024 | insidertrades.com

Insider Selling: Cryoport, Inc. (NASDAQ:CYRX) CEO Sells 57,039 Shares of Stock

April 16, 2024 | money.usnews.com

CryoPort Inc

April 4, 2024 | markets.businessinsider.com

Assessing CryoPort: Insights From 5 Financial Analysts

March 15, 2024 | finance.yahoo.com

Analysts Are Updating Their Cryoport, Inc. (NASDAQ:CYRX) Estimates After Its Full-Year Results

March 15, 2024 | markets.businessinsider.com

Analyst Ratings For CryoPort

April 20, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

March 14, 2024 | finanznachrichten.de

Cryoport, Inc.: Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results

March 14, 2024 | seekingalpha.com

Cryoport Tanks On Chilling Results And Bad Decisions

March 14, 2024 | finance.yahoo.com

Cryoport Full Year 2023 Earnings: EPS Misses Expectations

March 13, 2024 | markets.businessinsider.com

CryoPort Endorsed with ‘Buy’ Rating Amid Robust Commercial Growth and Dominant C> Market Presence

March 13, 2024 | markets.businessinsider.com

CryoPort’s Growth Trajectory: Navigating Temporary Setbacks with Strategic Acquisitions and Biopharma Recovery

March 13, 2024 | finance.yahoo.com

Cryoport, Inc. (NASDAQ:CYRX) Q4 2023 Earnings Call Transcript

March 13, 2024 | msn.com

S&P Futures Tick Higher Ahead of Key U.S. Inflation Report

March 13, 2024 | ca.finance.yahoo.com

Cryoport, Inc. (CYRX)

March 12, 2024 | stockhouse.com

Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results

March 12, 2024 | benzinga.com

Recap: CryoPort Q4 Earnings

March 11, 2024 | markets.businessinsider.com

CryoPort earnings: here's what Wall Street expects

March 3, 2024 | morningstar.com

CryoPort Inc CYRX

February 27, 2024 | prnewswire.com

Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

February 24, 2024 | ca.finance.yahoo.com

Matson, Inc. (MATX)

February 22, 2024 | benzinga.com

CryoPort Stock (NASDAQ:CYRX) Dividends: History, Yield and Dates

February 22, 2024 | benzinga.com

CryoPort Stock (NASDAQ:CYRX) Earnings Dates and Earning Calls

February 20, 2024 | finance.yahoo.com

MATX Jun 2024 80.000 put

February 17, 2024 | finance.yahoo.com

MATX Mar 2024 100.000 call

See More Headlines

Receive CYRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/12/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/02/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Transportation
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:CYRX
CUSIP: N/A
CIK: 1124524
Web: www.cryoport.com
Phone: (949) 470-2300
Fax: 949-470-2306
Employees: 1,170
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $18.63
High Stock Price Target: $28.00
Low Stock Price Target: $10.00
Potential Upside/Downside: +15.5%
Consensus Rating: Hold
Rating Score (0-4): 2.29
Research Coverage: 7 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($2.20)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-99,590,000.00
Net Margins: -42.69%
Pretax Margin: -42.59%
Return on Equity: -11.86%
Return on Assets: -5.99%

Debt

Debt-to-Equity Ratio: 0.82
Current Ratio: 11.73
Quick Ratio: 11.16

Sales & Book Value

Annual Sales: $233.26 million
Price / Sales: 3.40
Cash Flow: $0.38 per share
Price / Cash Flow: 42.92
Book Value: $9.45 per share
Price / Book: 1.71

Miscellaneous

Outstanding Shares: 49,164,000
Free Float: 44,198,000
Market Cap: $793.02 million
Optionable: Optionable
Beta: 1.60

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Mr. Jerrell W. Shelton (Age 79)
Chairman, President & CEO
Comp: $865.6k
Mr. Robert S. Stefanovich MS (Age 59)
CFO & Treasurer
Comp: $547.64k
Mr. Edward J. Zecchini (Age 62)
Senior VP and Chief Digital & Technology Officer
Comp: $85k
Dr. Mark W. Sawicki Ph.D.
Chief Scientific Officer
Mr. Thomas J. Heinzen
Vice President of Corporate Development & Investor Relations
Mr. Tony Ippolito
VP, General Counsel & Corporate Secretary
Ms. Kylie A. Crowe
Vice President of Global Human Resources & Organizational Development
Mr. Bret Bollinger (Age 57)
VP & Chief Innovation Officer
Comp: $140.49k
Mr. Phil Wilson
Chief Operating Officer of Cryoport Systems, LLC

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CYRX Stock Analysis - Frequently Asked Questions

Should I buy or sell Cryoport stock right now?: 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last twelve months. There are currently 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CYRX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CYRX, but not buy additional shares or sell existing shares.
View CYRX analyst ratings or view top-rated stocks.
What is Cryoport's stock price target for 2024?: 7 brokerages have issued 12-month price targets for Cryoport's shares. Their CYRX share price targets range from $10.00 to $28.00. On average, they predict the company's stock price to reach $18.63 in the next twelve months. This suggests a possible upside of 15.5% from the stock's current price.
View analysts price targets for CYRX or view top-rated stocks among Wall Street analysts.
How have CYRX shares performed in 2024?: Cryoport's stock was trading at $15.49 at the start of the year. Since then, CYRX shares have increased by 4.1% and is now trading at $16.13.
View the best growth stocks for 2024 here.
When is Cryoport's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our CYRX earnings forecast.
How were Cryoport's earnings last quarter?: Cryoport, Inc. (NASDAQ:CYRX) announced its earnings results on Tuesday, March, 12th. The company reported ($0.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.32) by $0.19. The business earned $57.26 million during the quarter, compared to the consensus estimate of $58.27 million. Cryoport had a negative trailing twelve-month return on equity of 11.86% and a negative net margin of 42.69%.
What ETF holds Cryoport's stock?: Inspire Small/Mid Cap ETF holds 20,223 shares of CYRX stock, representing 0.21% of its portfolio.

What guidance has Cryoport issued on next quarter's earnings?: Cryoport updated its FY 2024 earnings guidance on Tuesday, March, 12th. The company provided EPS guidance of for the period. The company issued revenue guidance of $242.0 million-$252.0 million, compared to the consensus revenue estimate of $253.2 million.
What other stocks do shareholders of Cryoport own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Amarin (AMRN), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Pfizer (PFE) and Block (SQ).
Who are Cryoport's major shareholders?: Cryoport's stock is owned by a number of institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (0.33%). Insiders that own company stock include Daniel M Hancock, Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Ramkumar Mandalam, Richard J Berman, Robert J Hariri and Robert Stefanovich.
View institutional ownership trends.
How do I buy shares of Cryoport?: Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CYRX) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cryoport (CYRX) Stock Price, News & Analysis

Cryoport MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Cryoport Stock (NASDAQ:CYRX)

CYRX Stock Price History

CYRX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

CYRX Stock Analysis - Frequently Asked Questions

Overall MarketRank^™